[1]
A. Kundu, A. Sen, S. Choudhury, T. Mandal, D. Guha, and S. Lahiry, “Immunohistochemical analysis of beta-catenin expression: a probable prognostic marker and potential therapeutic target in renal cell carcinoma”, Medicine and Pharmacy Reports, vol. 94, no. 1, pp. 65-72, Jan. 2021.